文献速递妇科产科

IIIC-IV期卵巢癌患者内脏腹膜减灭术(VPD)中肠切除后回肠造口术的并发症发生率与还纳率

Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-11-20

本研究回顾性分析2010年1月至2016年9月期间47例接受乙状结肠-直肠切除(SRR)后行转流性袢式回肠造口(DLI)的IIIC-IV期卵巢癌患者的资料。结果显示造口相关并发症发生率为46.8%,68.1%的患者造口还纳,未还纳的主要原因为肿瘤复发/进展(46.7%),还纳术后并发症发生率为37.1%。

要点

  • DLI造口相关并发症发生率为46.8%,17.0%的患者术后30天内再入院。
  • 68.1%的患者造口还纳,未还纳的主要原因为肿瘤复发/进展(7/15,46.7%)。
  • 还纳术后并发症发生率为37.1%,患者年龄、住院时间及VPD术后并发症与未还纳相关。

核心结论

  • 在本系列中,31.9%接受SRR和DLI的FIGO IIIC-IV期卵巢癌患者未还纳造口,总体造口相关并发症风险约45%,造口还纳相关并发症风险37%,该信息应纳入减灭术前的咨询过程,尤其对于可能需要肠切除的患者。

研究设计与样本

  • 回顾性研究,纳入研究期间(2010年1月至2016年9月)所有连续接受乙状结肠-直肠切除(SRR)后行转流性袢式回肠造口(DLI)的患者,完整数据47例。

主要发现

  • 造口相关并发症发生于22例患者(46.8%),8例患者(17.0%)术后30天内再入院。
  • 32例患者(68.1%)造口还纳,未还纳的主要原因为肿瘤复发/进展(7/15,46.7%)。
  • 患者年龄、住院时间、VPD术后并发症与DLI未还纳相关。
  • 从DLI形成至造口还纳的平均时间为6个月(±1.7)。
  • 还纳相关并发症发生于37.1%的患者。

临床怎么用

  • 原文未据此给出推荐,仅指出上述并发症与还纳率信息应作为减灭术前咨询过程的一部分,尤其对于可能需要肠切除的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the morbidity of diverting loop ileostomy (DLI) performed during Visceral Peritoneal Debulking (VPD) for stage IIIC-IV ovarian cancer and to report the rate, timing, and morbidity of DLI reversal. METHODS: We retrieved the data of all consecutive patients who underwent sigmoid-rectum resection (SRR) followed by DLI. Morbidity was defined as any surgical/medical complications clearly correlated to the DLI. The reversal rate of DLI was defined as the number of patients who had the continuity of the gastrointestinal tract restored in the study period. Finally, we recorded the timing and the morbidity of the reversal surgery. Factors associated with non-reversal of DLI were reported. RESULTS: In the study period (01/2010-09/2016), complete data were available for 47 patients. Stoma-related complications occurred in 22 patients (46.8%). Eight patients (17.0%) were readmitted within 30days from surgery. Thirty-two patients (68.1%) had their stoma reversed. The primary cause of non-reversal was tumor recurrence/progression (7/15, 46.7%). Patient's age, length of hospitalization, complications after VPD were associated with non-reversal of DLI. The mean time from DLI formation to stoma reversal was 6months (±1.7). Post-reversal related complications occurred in 37.1% of the patients. CONCLUSIONS: In our series, 31.9% of the patients with FIGO stage IIIC-IV ovarian cancer who underwent SRR and DLI did not have stoma reversal. Overall they had approximately 45% risk of stoma-related morbidity and 37% risk of morbidity related to the stoma reversal. This information should be part of the consulting process when preparing for debulking surgery, particularly in patients who are likely to need a bowel resection.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Tozzi R, Casarin J, Garruto-Campanile R, et al. Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol. 2017. PMID: 29169615. doi:10.1016/j.ygyno.2017.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。